Cardiac Interventions Today

AHA Calls for Improved Research of Asian American Cardiovascular Health

August 23, 2010—The American Heart Association (AHA) announced that, according to a scientific statement published in Circulation, there are marked differences in heart disease risk and occurrence among Asian American subgroups, but data on these subgroups are limited. Because of this, the AHA is calling for more research on this fastest-growing racial/ethnic group in the United States. The call to action document is available online ahead of print.

Svelte Medical’s Acrobat Coronary Stent System Receives CE Mark Approval

August 23, 2010—Svelte Medical Systems, Inc. (New Providence, NJ) announced that it has received CE Mark approval to market the Acrobat stent-on-a-wire (SOAW) bare-metal coronary stent system in the European Union.

ACCF Joins SCAI as Partner in Accreditation of Cardiovascular Facilities

August 19, 2010—The Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology Foundation (ACCF) announced an agreement to jointly sponsor the Accreditation for Cardiovascular Excellence (ACE) organization. Facilities seeking ACE accreditation can obtain more information and complete the application process at www.cvexcel.org.

Biotronik Begins BIOSOLVE Study of Its Drug-Eluting Absorbable Metal Stent

August 13, 2010—Biotronik AG (Bülach, Switzerland) announced that its DREAMS (Drug-Eluting Absorbable Metal Scaffold) device has been successfully implanted in the first patient as part of the first-in-man BIOSOLVE-I clinical study of this new treatment for coronary artery disease. BIOSOLVE-I is a prospective, nonrandomized study that will enroll patients at six centers in Germany, Belgium, the Netherlands, and Switzerland. Further enrollment in BIOSOLVE-I is planned to begin in all centers shortly.

News